Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Konstantin Mechler

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Trials|March 18, 2016
Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) - study protocol for a randomised controlled trialAlexander Häge, Tobias Banaschewski, Jan K Buitelaar, et al.
Journal of Inherited Metabolic Disease|August 27, 2020
Quantitative retrospective natural history modeling for orphan drug developmentSven F Garbade, Matthias Zielonka, Shoko Komatsuzaki, et al.
Brain Sciences|December 24, 2021
Actigraphy-Derived Sleep Profiles of Children with and without Attention-Deficit/Hyperactivity Disorder (ADHD) over Two Weeks-Comparison, Precursor Symptoms, and the ChronotypeMirjam Ziegler, Anna Kaiser, Christine Igel, et al.
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|September 19, 2017
Glutamatergic Agents in the Treatment of Compulsivity and Impulsivity in Child and Adolescent Psychiatry: a Systematic Review of the LiteratureKonstantin Mechler, Alexander Häge, Nina Schweinfurth, et al.
Scientific Reports|October 23, 2025
Insights from 24-hour actigraphy using functional linear modeling in children with and without ADHDMirjam Ziegler, Pascal Maurice Aggensteiner, Katja Becker, et al.
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|June 23, 2025
Medication Nonadherence in Children and Adolescents with ADHDKonstantin Mechler, Tobias Banaschewski, Tobias Hellenschmidt, et al.
BMC Psychiatry|October 12, 2018
Effects of long-term methylphenidate use on growth and blood pressure: results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)Suzanne McCarthy, Antje Neubert, Kenneth K C Man, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|June 24, 2021
Personalized at-home neurofeedback compared to long-acting methylphenidate in children with ADHD: NEWROFEED, a European randomized noninferiority trialDiane Purper-Ouakil, Hilario Blasco-Fontecilla, Tomas Ros, et al.
Frontiers in Psychiatry|February 5, 2024
Limited usefulness of neurocognitive functioning indices as predictive markers for treatment response to methylphenidate or neurofeedback@home in children and adolescents with ADHDAnna Kaiser, Pascal M Aggensteiner, Hilario Blasco Fontecilla, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Trials|March 18, 2016
Glutamatergic medication in the treatment of obsessive compulsive disorder (OCD) and autism spectrum disorder (ASD) - study protocol for a randomised controlled trialAlexander Häge, Tobias Banaschewski, Jan K Buitelaar, et al.
Journal of Inherited Metabolic Disease|August 27, 2020
Quantitative retrospective natural history modeling for orphan drug developmentSven F Garbade, Matthias Zielonka, Shoko Komatsuzaki, et al.
Brain Sciences|December 24, 2021
Actigraphy-Derived Sleep Profiles of Children with and without Attention-Deficit/Hyperactivity Disorder (ADHD) over Two Weeks-Comparison, Precursor Symptoms, and the ChronotypeMirjam Ziegler, Anna Kaiser, Christine Igel, et al.
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|September 19, 2017
Glutamatergic Agents in the Treatment of Compulsivity and Impulsivity in Child and Adolescent Psychiatry: a Systematic Review of the LiteratureKonstantin Mechler, Alexander Häge, Nina Schweinfurth, et al.
Scientific Reports|October 23, 2025
Insights from 24-hour actigraphy using functional linear modeling in children with and without ADHDMirjam Ziegler, Pascal Maurice Aggensteiner, Katja Becker, et al.
Zeitschrift Fur Kinder- Und Jugendpsychiatrie Und Psychotherapie|June 23, 2025
Medication Nonadherence in Children and Adolescents with ADHDKonstantin Mechler, Tobias Banaschewski, Tobias Hellenschmidt, et al.
BMC Psychiatry|October 12, 2018
Effects of long-term methylphenidate use on growth and blood pressure: results of the German Health Interview and Examination Survey for Children and Adolescents (KiGGS)Suzanne McCarthy, Antje Neubert, Kenneth K C Man, et al.
Journal of Child Psychology and Psychiatry, and Allied Disciplines|June 24, 2021
Personalized at-home neurofeedback compared to long-acting methylphenidate in children with ADHD: NEWROFEED, a European randomized noninferiority trialDiane Purper-Ouakil, Hilario Blasco-Fontecilla, Tomas Ros, et al.
Frontiers in Psychiatry|February 5, 2024
Limited usefulness of neurocognitive functioning indices as predictive markers for treatment response to methylphenidate or neurofeedback@home in children and adolescents with ADHDAnna Kaiser, Pascal M Aggensteiner, Hilario Blasco Fontecilla, et al.
Pageof 3